Respiratory Foundation
Acute asthma exacerbation at a fun run
Adult · 28yr · female
Patient Information
- Dispatch
- You are called to a 28-year-old female who has come to the FAP during the City to Surf Fun Run. She is sitting upright and appears short of breath. (Sarah Nolan)
- Patient
- Sarah Nolan — 28yr (65kg)
- Incident History
- Pt was approximately 8km into the fun run when she developed increasing shortness of breath, chest tightness and audible wheeze. She walked herself to the FAP.
- Emergency Contact
- Marcus Nolan (Husband) — 0412 773 405
Initial Rapid Assessment
- Response
- Alert
- Airway
- Patent. Nil obstruction. Nil stridor.
- Breathing
- Increased work of breathing. Audible expiratory wheeze. Unable to speak in full sentences. RR 26. SpO2 91% on room air.
- Circulation
- Radial pulse present, regular, slightly elevated. Skin warm and diaphoretic. Nil active bleeding.
- Disability
- GCS 15 (E4V5M6). Alert and oriented to time, place and person. Appears anxious.
- Exposure
- No rashes, urticaria or angioedema visible. No signs of trauma.
Vitals
| Time | SpO2 | Resp Dist | RR | Pulse | BP | CRT | GCS | PERL | Temp | BGL | Pain |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Initial | 91% (RA) | Severe | 26 | 112 | 128/82 | <2s | 15 | 4 4 ++ | 37.1 | – | 4 |
| 10 mins | 96% (O2 simple mask 6L/min) | Mild | 18 | 98 | 122/78 | <2s | 15 | 4 4 ++ | 37.1 | – | 2 |
History Taking
- Signs/Symptoms
- Shortness of breath, chest tightness, audible wheeze, dry cough.
- Allergies
- No known drug allergies. Known allergy to cats (triggers asthma).
- Medications
- Salbutamol (Ventolin) MDI — prescribed PRN. No preventer inhaler. No other regular medications.
- Pertinent History
- Known asthmatic since childhood. Has not needed her reliever puffer for approximately 6 months. No prior ICU admissions or intubations. No recent ED visits for asthma.
- Last Oral Intake
- Light breakfast and water approximately 2 hours ago.
- Events Leading
- Running in the City to Surf Fun Run. Weather is warm with moderate pollen count. Pt did not warm up before the race.
- Treatment Prior
- Pt attempted to use her own Ventolin puffer prior to arrival at FAP — took 2 puffs without a spacer. Minimal relief.
- Onset
- Gradual onset approximately 20 minutes ago during the run, worsening over last 10 minutes.
- Pain
- Chest tightness — central, non-radiating.
- Quality
- Tight, constricting sensation in chest. Wheeze on breathing out.
- Radiates
- Nil radiation.
- Severity
- 4/10 chest tightness. Breathing difficulty rated 7/10.
Treatment Response
Diagnosis
This patient is suffering from a severe acute asthma exacerbation triggered by exercise.
Facilitator Triggers — if trainees miss a critical step
- ! (If trainees do not sit the patient upright or allow her to adopt a position of comfort within the first 2 minutes, increase the patient's distress — she becomes more anxious and SpO2 drops to 89%.)
- ! (If oxygen is not applied within 3 minutes of assessment, RR increases to 30 and SpO2 drops to 88% on room air.)
- ! (If trainees attempt to use the patient's own Ventolin MDI without a spacer, remind them that MDI must be administered via spacer as per CPG — prompt: 'Do you have a spacer available?')
- ! (If salbutamol via spacer is not administered within 5 minutes of recognising severe wheeze, the patient becomes unable to speak in more than 2-word sentences and SpO2 drops to 87%.)
- ! (If trainees consider anaphylaxis — correct them only if they do NOT also check for urticaria, angioedema or other anaphylaxis features; if they check and rule it out, this is appropriate clinical reasoning.)
- ! (If trainees ask about prior asthma severity or risk factors, reward this as good history-taking — no change to scenario.)
Treatment Objectives
- 1 Ensure scene safety and don appropriate PPE.
- 2 Perform Primary Survey — identify severe respiratory distress with audible wheeze and SpO2 91% on room air.
- 3 Position patient sitting upright or in a position of comfort — do not lay patient flat.
- 4 Apply oxygen via simple face mask at 5–8 L/min titrated to target SpO2 92–95%.
- 5 Perform Vital Sign Survey including RR, SpO2, HR, BP, GCS and pain score.
- 6 Take IMISTAMBO history — confirm known asthma, current medications, allergies, prior severity, and events leading to presentation.
- 7 Determine asthma severity — classify as SEVERE based on: unable to complete sentences, accessory muscle use, SpO2 90–94%, RR >25.
- 8 Assess for anaphylaxis — confirm no urticaria, angioedema, stridor or other allergic features before proceeding with asthma management.
- 9 Prepare Salbutamol (Ventolin) MDI with spacer (Space Chamber or Lite Aire spacer).
- 10 Administer Salbutamol 400–1200 microg (4–12 puffs) via MDI and spacer — for severe exacerbation administer up to 12 puffs (1200 microg) via spacer. Confirm 6 medication rights: right patient, right drug, right dose, right route, right time, right documentation.
- 11 Reassess SpO2, RR and work of breathing 5 minutes post salbutamol administration.
- 12 Repeat Salbutamol 400–1200 microg (4–12 puffs) via MDI and spacer every 20 minutes as clinically indicated if bronchospasm persists.
- 13 Record full observations every 10 minutes (or 5 minutes if time critical).
- 14 Be alert for rapid deterioration — reassess severity classification after each intervention.
- 15 Arrange transport to hospital — call for ambulance if patient does not respond to initial treatment or is time critical.
- 16 Scenario ends on arrival of ambulance and IMISTAMBO handover.
- 17 Attention to hand hygiene will be given throughout the scenario.
Clinical references: Asthma exacerbation · Salbutamol Sulphate · Oxygen · MDI & Space Chamber
How did you go?
Report a clinical error
Describe what you believe is incorrect. A clinical reviewer will be notified.